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Abstract: In this study we demonstrate a new in-fermenter
chemical extraction procedure that degrades the cell wall
of Escherichia coli and releases inclusion bodies (IBs) into
the fermentation medium. We then prove that cross-flow
microfiltration can be used to remove 91% of soluble con-
taminants from the released IBs. The extraction protocol,
based on a combination of Triton X-100, EDTA, and in-
tracellular T7 lysozyme, effectively released most of the in-
tracellular soluble content without solubilising the IBs.
Cross-flow microfiltration using a 0.2 Am ceramic mem-
brane successfully recovered the granulocyte macrophage-
colony stimulating factor (GM-CSF) IBs with removal of
91%of the soluble contaminants and virtually no loss of IBs
to the permeate. The filtration efficiency, in terms of both
flux and transmission, was significantly enhanced by in-
fermenter BenzonaseR digestion of nucleic acids follow-
ing chemical extraction. Both the extraction and filtration
methods exerted their efficacy directly on a crude fermen-
tation broth, eliminating the need for cell recovery and re-
suspension in buffer. The processes demonstrated here can
all be performed using just a fermenter and a single cross-
flow filtration unit, demonstrating a high level of process
intensification. Furthermore, there is considerable scope to
also use the microfiltration system to subsequently solubi-
lise the IBs, to separate the denatured protein from cell
debris, and to refold the protein using diafiltration. In this
way refolded protein can potentially be obtained, in a rela-
tively pure state, using only two unit operations. B 2004
Wiley Periodicals Inc.
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INTRODUCTION
There is an increasing need to express and purify proteins to
add value to the human genome sequencing effort, and
to speed the commercialisation of new biopharmaceutical
products. The bacterium Escherichia coli is a widely used
expression system as it offers advantages including high
expression yield, known molecular biology, and simple
culturing procedures. However, overexpressed protein in
E. coli is often sequestered into biologically inactive and
insoluble aggregates, known as inclusion bodies (IBs)
(Marston, 1986; Mitraki et al., 1991). Efficient ways of
processing IBs at both industrial and laboratory scale are
required. Ideally, such methods should use technology that is
approximately scale-invariant, is easily automated for high-
throughput processing, is generic for a broad range of similar
proteins, and is economical (Middelberg, 2002). The
conventional laboratory process for IBs employs mechanical
disruption of the cells, usually by sonication, followed by
repeated cycles of enzymatic and chemical treatment
interspersed with centrifugal washing (Clark et al., 1999).
This process is both time-consuming and labour-intensive,
and is difficult to economically scale. The procedures are
often simplified on scale-up by reducing the rigour of
treatment and washing, leading to inefficiencies in sub-
sequent downstream processing operations including cen-
trifugation (Middelberg, 2002; Choe et al., 2002).
It is apparent that conventional methods for IB processing
do not satisfy the criteria specified earlier. To address this,
we have recently developed chemical methods that extract
intracellular insoluble protein at high efficiency using
chaotrope-based solutions (Falconer et al., 1998; Choe and
Middelberg, 2001a). We have also demonstrated a method
for selectively removing DNA from the chemical extraction
mixture using spermine (Choe and Middelberg, 2001b).
These extraction methods have been successfully coupled
with primary capture methods including expanded bed
chromatography (Choe et al., 2002) and high-gradient
magnetic separation (Choe, 2002). However, this chemical
extraction technique is suitable only for those proteins that
are not degraded by proteases associated with the cell wall.
Such proteases can rapidly degrade protein product, even in
concentrated chaotrope, and can lead to significant product
loss (Babbitt et al., 1991; Wong et al., 1996). For such
proteins, complete chemical extraction will prove subopti-
mal. The aim of the research reported here was to develop an
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approach for IB processing that meets the criteria specified
earlier. A primary objective was to maintain the protective
IB state until contaminating proteins had been removed. A
secondary objective was to minimise the number of unit
operations involved in the process, thus minimising process
and validation costs (Gehmlich et al., 1997) while also
simplifying the ease and economy of laboratory automation.
Our concept is to couple nonsolubilising chemical extraction
with cross-flow microfiltration. Other researchers have
developed chemical extraction techniques for E. coli that
selectively disrupt the cell envelopes under nonsolubilising
conditions (Hettwer and Wang, 1989; Naglak et al., 1990;
Middelberg, 1995). The combined use of guanidine hydro-
chloride (GuHCl, 0.1 M) and Triton X-100 (0.5% v/v)
permeabilised E. coli cells giving 50–60% protein release
(Hettwer and Wang, 1989). The use of chaotropic agents,
such as GuHCl or urea, to solubilise protein from E. coli
membrane fragments, and use of Triton X-100 as a nonionic
detergent to solubilise the E. coli inner membrane, has also
been reported (Novella et al., 1994). While these techniques
are good for differentially releasing soluble target pro-
tein, they are inefficient if the product is an IB, as more than
50–60% removal of contaminating proteins is required. A
method to recover IGF IBs by means of reversible oxidation
of the IB surface has been developed by Falconer et al.
(1999). Initial permeabilisation using a combination of
chaotrope, EDTA, and oxidising agent rendered the IB
refractory to dissolution, and this process could be reversed
by the use of DTT in a second step (after removal of the
soluble contaminating protein). The general applicability of
this method has not, however, been demonstrated. A
nonsolubilising commercial bacterial-extraction kit for IB
processing has been recently introduced (Pierce Biotechnol-
ogy, Rockford, IL). The package makes use of the existing
Pierce B-PER Bacterial Protein Extraction Product (Pierce,
Product 78243, which contains a nonionic detergent in
20 mM Tris) to disrupt the bacterial cell membrane,
supplemented with lysozyme (Pierce, Product 89833).
However, the cost of lysozyme can be prohibitive at large
scale. Studier (1991) developed a system for the intracellular
expression of T7 lysozyme expressed intracellularly by host
cells carrying pLysS or pLysL plasmids, which might be
useful to overcome lysozyme cost limitations. It was
reported that thorough bacterial cell lysis can be achieved
when cells resuspended in 50 mM Tris-HCl, 2 mM sodium
EDTA (pH 8.0) were treated with detergent (e.g., 0.1% (v/v)
Triton X-100 or 0.2% (w/v) deoxycholate) or 1% (v/v)
chloroform. This technique is cost-efficient in terms of
lysozyme use, but the procedure assumes that cells are
collected and resuspended in buffer prior to chemical
treatment. From the above studies, we conclude that a
combination of mild chaotrope, EDTA, lysozyme, and
nonionic detergent (Triton X-100) would seem appropriate
for further investigation.
Several studies have reported the feasibility of using
microfiltration in cross-flow diafiltration mode for IB
recovery from cell lysate. Meagher et al. (1994) recovered
rIL-2 IBs from an E. coli cell lysate using a 0.1 Am Durapore
hydrophilic membrane to remove 85–90% of the UV 280 nm
absorbing compounds to the permeate. Forman et al. (1990)
recovered IBs of the gp41 transmembrane protein of the
HTLV-III virus from an E. coli lysate using a 0.45 Am
Durapore membrane. Up to 87% of the soluble protein was
removed using three volumes of buffer exchange. In a
microfiltration study to purify human growth hormone IBs
from a homogenised E. coli cell lysate, removal of greater
than 90% of soluble protein using a 0.15 Am cellulose acetate
membrane and a 0.1 Am polyether-sulfone membrane has
also been reported (Bailey and Meagher, 1997, 2000).
However, these studies have only considered the recovery of
IBs from cells following mechanical disruption, and have
not considered recovery from complex chemical extraction
mixtures. In this work we extend these previous studies by
coupling nonsolubilising chemical extraction with cross-
flow microfiltration for the preparation of clean IBs of
granulocyte macrophage-colony stimulating factor (GM-
CSF). Importantly, we perform nonsolubilising extraction
directly in fermentation media using a mixture of Triton X-
100 and EDTA, coupled with enzymatic attack of the cell
wall using constitutively expressed intracellular T7 lyso-
zyme encoded by the pLysS plasmid in E. coli BL21(DE3)-
pLysS (Studier, 1991). By performing the extraction
directly in fermentation media we minimise the number of
unit operations: only a fermenter and a cross-flow micro-
filtration system are required. We also demonstrate that
extracted IBs can be efficiently separated from contaminat-
ing proteins using nuclease treatment and cross-flow micro-
filtration, despite the presence of Triton X-100, yielding a
high-purity product having good refolding characteristics.
MATERIALS AND METHODS
Materials
Native granulocyte macrophage-colony stimulating factor
(GM-CSF) and GM-CSF IBs purified by preparative
reversed-phase chromatography were kindly supplied by
Novartis Pharma AG (Basel, Switzerland). Guanidine
hydrochloride (GuHCl), oxidised and reduced glutathione
(GSSG and GSH), Tris-HCl, cupric chloride, and ethyl-
enediaminetetraacetic acid (EDTA) were purchased from
Sigma-Aldrich (Poole, Dorset, UK) and were ACS reagent
grade. Terrific broth (modified powder), carbenicillin
disodium salt, chloramphenicol, magnesium chloride, and
Benzonase were from Sigma-Aldrich. Dithiothreitol (DTT)
and isopropyl h-D-1-thiogalactopyranoside (IPTG) were
from Melford Laboratories (Chelsworth, UK). Triton X-100
(t-octylphenoxypolyethoxyethanol, 98%) was purchased
from BDH Chemicals (Poole, UK). Sodium hydroxide
pellet, HPLC-grade acetonitrile, and trifluoroacetic acid
(TFA) were purchased from Fisher Scientific (Lough-
borough, UK). Sodium hypochlorite solution (f13% active
chlorine) was purchased from Fluka (Poole, Dorset, UK).
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Analytical Methods
Extraction Efficiency Using SDS-PAGE Analysis
Extraction efficiency was evaluated qualitatively using
SDS-PAGE analysis. One mL of extraction broth was
centrifuged at 10,000g for 15 min at 4jC. The supernatant
was collected and the pellet was washed 1with PBS buffer
byf30 sec of vortexing. The pellet was resuspended in 1 mL
of solubilising buffer by 1 min of vortexing (50 mM Tris-
HCl, 1 mM EDTA, 8 M urea, 100 mM DTT, pH 8). Fifty AL
of the sample was mixed with 50 AL of sample buffer
(Laemmli 2 concentrate, Sigma-Aldrich), boiled for 4 min,
and centrifuged (14,000g, 1 min). Thirty AL of sample was
loaded on a SDS-PAGE gel (8–16% Ready Precast Gel,
50 AL well, Bio-Rad Laboratories, Hempsted, UK) prior to
electrophoresis (run for 2 h at a fixed voltage of 80 V and an
initial current of 25 mA).
Total Protein Assay for Evaluating Microfiltration
Efficiency
Microfiltration efficiency was assessed by comparing pro-
tein concentration in the final retentate with that in the feed.
Total protein was measured using Bio-Rad protein assay dye
reagent, 5 concentrate (Catalog no. 500-0006, Bio-Rad
Laboratories) based on the Bradford assay (Bradford, 1976)
using a bovine serum albumin (BSA) standard.
Agarose Gel Electrophoresis
DNA molecular weight in samples from chemical extraction
was estimated on a 1% (w/v) agarose gel using a Sub-Cell
GT Agarose Gel Electrophoresis System (Bio-Rad, 170-
4402) with a molecular marker (Invitrogen Life Technolo-
gies, 15615-016, Paisley, UK). Two AL of sample was mixed
with 2 AL of gel loading solution (Sigma, G2526), 2 AL of the
mixture was loaded onto the 1% agarose gel.
RP-HPLC Analysis
The concentrations of native GM-CSF, denatured GM-CSF
from solubilised IBs, and refolded GM-CSF were measured
using a C5 Jupiter reversed-phase column (5 Am, 300 A˚,
150  4.6 mm, Phenomenex, Macclesfield, UK) on a high-
performance liquid chromotography (HPLC) system com-
prising a X-Act 4-Channel Degassing Unit (Jour Research,
Sweden), a 7725I Injection Valve (Rheodyne, Cotati, CA,
USA), two HPLC 422 Pumps (Kontron Instruments, UK), a
C030 HPLC column chiller/heater (Torrey Pines Scientific,
San Marcos, CA, USA), a 2151 Variable Wavelength
Detector (LKB, Sweden), and Chromeleon HPLC Manage-
ment Software (Dionex, Sunnyvale, CA, USA). The
denatured and refolded samples were acidified to 0.4 and
0.2% (v/v) TFA, respectively, prior to sample injection. An
acetonitrile-water gradient (from 26–38% (v/v) acetonitrile
over 3.5 min, followed by 38–42% over 0.5 min and then
42–60.25% over 15 min) with 0.1% (v/v) TFA counterion
was used to elute samples, at a total solvent flow-rate of
0.5 mL min1. Absorbance was measured at 214 nm.
Native GM-CSF and GM-CSF IBs purified by preparative
reversed-phase chromatography were kindly supplied by
Novartis Pharma AG (Basel, Switzerland) to enable system
calibration. Denatured GM-CSF was prepared by solubilis-
ing these IBs in GuHCl-buffer (50 mM Tris-HCl, 7M
guanidine hydrochloride (GuHCl), 50 mM DTT, pH 8.0)
overnight at 4jC. Native GM-CSF was analysed following
resuspension of the freeze-dried powder in TE buffer
(50 mM Tris, 1 mM EDTA) pH 8.
Molecular Biology and Cell Suspension Preparation
Molecular Biology
Granulocyte macrophage-colony stimulating factor (GM-
CSF)/pET17b plasmid was kindly provided by Novartis
Pharma. Competent E. coli cell strain BL21(DE3)pLysS
(Novagen, 70236-3, Madison, WI, USA) were transformed
with this plasmid. Strains having the designation (DE3) are
lysogenic for a E prophage that contains an IPTG-inducible
T7 RNA polymerase. Strains having the pLysS designation
carry a pACYC184-derived plasmid that encodes T7
lysozyme, which is a natural inhibitor of T7 RNA poly-
merase that serves to repress basal expression of target
genes under the control of the T7 promoter. The existence
of cytoplasmic T7 lysozyme has been reported to facilitate
the production of cell extracts for purification of target
protein (Studier, 1991). Transformed cells were grown on
1.5% agarose gel (Bacto agar, Difco, Detroit, MI, US) with
Luria Broth, LB (Miller’s modification, Sigma L3397) and
incubated overnight at 37jC. The growth medium was
supplemented with 50 Ag mL1 of carbenicillin and
34 Ag mL1 of chloramphenicol. A single colony of the
transformed cells was inoculated in a 250 mL baffled
Erlenmeyer flask containing 26 mL of TB medium. The
culture was harvested at OD 18 measured at 600 nm,
centrifuged at 8,000g for 15 min, and transferred into
cryotubes (Technical Service Consultants, Protect Bacterial
Preservative System TS70-AP, UK) for storage at –80jC.
Shake Flask Cultures
To prepare the inoculum for the shake-flask culture, a bead
coated with E. coli BL21(DE3)pLysS was picked from a
cryotube using a sterile plastic inoculating loop and added in
a 250 mL baffled Erlenmeyer flask containing 26 mL of TB
medium. The culture was mixed by agitation for 18–24 h
using a platform shaker set at 200 rpm and 37jC. Two mL of
the inoculum was inoculated into a 250 mL baffled
Erlenmeyer flask containing 26 mL of TB medium. In all
cases, the TB medium was supplemented with 50 Ag mL1
of sterilised carbenicillin and 34 Ag mL1of chlorampheni-
col in ethanol immediately before inoculation. The culture
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was incubated in a horizontal shaker at 200 rpm and 37jC.
When the optical density, measured at 600 nm (OD600)
reached 5.5F 0.5, the culture was induced with 1 mM IPTG.
Following confirmation that the culture was in its stationary
phase by measuring the optical density of culture broth at
600 nm using a spectrophotometer (OD600 of 16F 2, culture
time of 4 F 0.5 h), the culture was terminated. In the case
where pellet collection was necessary (e.g., for B-PER
control extractions), culture was centrifuged at 8,000g for
15 min. For chemical extraction without removal of the
growth medium, the cell culture was pipetted directly into
50 mL Falcon tubes containing preweighed chemical ex-
traction reagents (in powder form).
Fermentations
To prepare the inoculum for fermentation, a bead coated
with E. coli BL21(DE3)pLysS was picked from a cryotube
using a sterile inoculate loop and added in a 250 mL baffled
Erlenmeyer flask containing 100 mL of TB medium.
Cultures were prepared with agitation using a platform
shaker set at 200 rpm and 37jC (18–24 h). TB with the
addition of 10 g L1 glycerol and 0.25 mL L1 poly-
propylene glycol (PPG; BDH, 297676Y, Poole, UK) was
used as fermentation medium. Carbenicillin and chloram-
phenicol were added to a final concentration of 50 and
34 Ag mL1, respectively, immediately before inoculation.
All fermentation work was conducted using a 5 L fermentor
(4 L working volume, New Brunswick Scientific, Edison,
NJ, USA, BioFlo 3000). Agitation-DO cascade control was
applied to maintain a DO level above 20% and temperature
was controlled at 37jC. Pure oxygen supply was mixed with
the air inlet when agitation control alone was not adequate to
keep the DO at its set point. Induction of GM-CSF
expression was done by adding IPTG to a final concentration
of 1 mM when OD600 reached 5.5 – 6.0. Following
confirmation that the culture was in its stationary phase by
measuring the optical density of culture broth at 600 nm
using a spectrophotometer (OD600 of 16F 2, induction time
of 4 F 0.5 h), fermentation was terminated. Chemical
extraction reagents in powder form were then added directly
into the fermenter and agitated at 800 rpm for 40 min. The
pH and DO sensor probes were removed from the fermenter
during this chemical extraction procedure.
Chemical Extraction
Chemical Extraction Benchmarking Using B-PERR
Reagent
B-PER Bacterial Protein Extraction Reagent (Pierce,
78243) was used as described by the manufacturer, without
the addition of extracellular lysozyme, as a control for the
extraction methods screened in this study. Supernatant and
pellet samples were analysed by SDS-PAGE.
Evaluation of Chemical Extraction Methods:
Denaturing Selective Extraction
An extraction procedure reported by Falconer et al. (1999)
achieved the selective extraction of an insoluble variant of
insulin-like growth factor by using reversible oxidation. In
this work, we examine the effectiveness of the first-stage
extraction in removing the intracellular soluble contami-
nants without solubilising the GM-CSF IBs. One mL of
culture broth in a 2 mL microcentrifuge tube was first
centrifuged (8,000g, 4jC, 15 min). Cell pellets were resus-
pended in 1 mL of first-stage extraction buffer (0.1 M Tris,
3 mM EDTA, 20 mM 2-hydroxyethyl disulphide (2-HEDS),
pH 9.0 containing either 4, 6, or 8 M urea). The extraction
broth was stirred at 200 rpm and 37jC for various times
(30 min, 2 h, and overnight). Extraction efficiency was
evaluated using SDS-PAGE by analysing the soluble and
insoluble fractions.
Evaluation of Chemical Extraction Methods:
Nonsolubilising Extraction
Ten mL of shake-flask cell suspension at an OD600 of 16
F 2 were aliquoted into 50 mL Falcon tubes without
separating the growth medium. The tubes were filled with
different extraction reagents (all in powder form except for
Triton X-100 which was in concentrated liquid form, 98%
purity) to give the extraction conditions listed in Table I.
Upon dissolution of the reagents, the pH of the extraction
broth was adjusted to 9.0 using 8 M sodium hydroxide
(NaOH). All samples were agitated on a horizontal shaker
at 200 rpm and 37jC for 30 or 60 min. Extraction
efficiency was evaluated using SDS-PAGE.
Larger Scale In Situ Chemical Extraction
Chemical extraction was performed in the 5-L fermenter by
the direct addition of concentrated extraction chemicals
(powdered EDTA and Tris and concentrated 98% purity
Triton X-100) to the fermentation suspension, without prior
removal of fermentation media. Chemicals were added to
give a final extraction environment of 0.05% (v/v) Triton
X-100, 5 mM EDTA, 0.1 M Tris, pH 9 by addition of 8 M
NaOH (plus undefined media components). Extraction was






1 B-PER Unknown Unknown 5
2 2M Urea — 5 30 and 60
3 — 0.1 — 30 and 60
4 — 0.1 5 30 and 60
5 2M Urea 0.1 5 30 and 60
6 — 0.1 10 30 and 60
7 — 0.05 5 30
*Assuming the stock solution of Trion X-100 has f100% purity
instead of f98%.
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performed for 30 min at an impeller speed of 300 rpm and a
temperature of 37jC. Agitation speed was increased to
800 rpm for 40 min to counter the increase in medium vis-
cosity caused by the release of the intracellular nucleic acids.
Extraction efficiency was evaluated using SDS-PAGE.
Reduction of Nucleic Acid Fragment Size Using
Benzonase
A significant increase in viscosity and non-Newtonian
behaviour was observed during in situ chemical extraction.
Benzonase (Sigma, E1014) treatment was employed to
provide a suspension suitable for further processing (i.e.,
prior to microfiltration), as it is effective over a wide range
of operating conditions (Table II). Tests were conducted to
assess the effect of chemical extraction conditions on
Benzonase efficiency. Initial experiments investigated the
impact of broth dilution, as TB medium contains at least
54 mM K2HPO4 and 16 mM of KH2PO4. The need for
MgCl2 addition to neutralise excess EDTA was also
investigated. Test samples of chemical extraction medium
diluted and/or supplemented with appropriate concentra-
tions of MgCl2 were treated with 50 and 100 U mL
1 of
Benzonase and were incubated at room temperature for 2 h.
Efficiency was significantly improved by dilution. Further
tests aimed to reduce the concentration of Benzonase. Two-
fold diluted extracts were incubated in 50, 30, 20, and
10 U mL1 of Benzonase, in the presence of 6 mM MgCl2,
for 30 min and overnight (14–18 h). In all cases, digestion
efficiency was analysed by agarose gel electrophoresis.
Cross-Flow Microfiltration
Following chemical extraction to release intracellular
soluble contaminants, a cross-flow microfiltration unit
(Pilot Unit X-LAB 3, Exekia, Bazet, France) was used to
remove the soluble contaminants (as permeate) from the
IBs. This unit comprises a 3 L feed tank with a double
jacket for temperature control, a Membralox component
holding a single cylindrical ceramic filtration ‘‘monotube’’
and a cross-flow volumetric pump providing a fixed cross-
flow rate of f1 m3 h1. Transmembrane-pressure was
generated by pressurising the feed tank. The ceramic mono-
tube (T1-70 Membralox, Exekia) has a filter area of 50 cm2,
7 mm i.d., 10 mm o.d., is 25 cm in length, and is available in
various microfiltration pore sizes (0.1, 0.2, 0.5 Am). Initial
microfiltration tests using a 0.1 Am pore size and a
transmembrane-pressure (TMP) of 0.5 bar gave very poor
protein transmission based on Bradford protein assay and
SDS-PAGE of the permeate (data not shown). A small-scale
test using manual filtration with a 0.1 Am filter (Whatman
10 mm syringe filter, Anotopy, Maidstone, UK) confirmed
poor transmission for this complex extraction mixture.
Similar tests using a 0.2 Am filter gave good transmission, so
a 0.2 Am monotube was selected for further investigation.
Microfiltration of Untreated Chemical Extraction
Broth
Chemical extraction broth (750 mL) was diluted with
750 mL of TE buffer (50 mM Tris and 1 mM EDTA, pH 8).
A two-volumes buffer exchange (3,000 mL TE buffer) was
carried out at a constant TMP of 0.5 bar for 0 to 5 h, and at
0.75 bar from 5 to f12 h. Pulsed backwashing was
employed every 5 min throughout the filtration process and
the diafiltration operation worked incrementally by adding
150 mL of TE buffer every time 150 mL of permeate had
been removed. Permeate samples were collected at variable
time intervals throughout the filtration, while duplicated
1 mL retentate samples were withdrawn after each volume
(1500 mL) of buffer exchange. A new 0.2 Am ceramic
monotube was used for this experiment.
Microfiltration of Sheared Chemical Extraction Broth
Chemical extraction broth (750 mL) was sheared for 20 min
using a hand-mixer device (Multipimer MR400, Braun,
UK). Samples were taken at 10, 15, and 20 min and analysed
for DNA size using agarose gel electrophoresis (see
Analytical Methods, above). The sheared extract was diluted
2-fold with 750 mL of TE buffer, pH 8. A 1.5 volumes buffer
exchange (2,250 mL TE buffer) was carried out at a constant
TMP of 0.5 bar for 0 to 5 h, and at 0.75 bar from 5 tof12 h.
Pulsed backwashing was employed every 5 min throughout
the filtration process, and the diafiltration operation worked
incrementally by adding 150 mL of TE buffer every time
150 mL of permeate had been removed. Permeate samples
were collected at variable time intervals throughout the
filtration, while duplicated 1 mL retentate samples were
withdrawn at one volume (1,500 mL) and 1.5 volumes
(2,250 mL) of buffer exchange. A new 0.2 Am ceramic
monotube was used for this experiment.
Microfiltration of Benzonase-Treated Chemical
Extraction Broth
Chemical extraction broth (750 mL) was diluted with
750 mL of TE buffer (pH 8) to reduce ionic strength and
Table II. Optimal and effective operating conditions for Benzonase
nuclease.
Condition Optimala Effectiveb
Mg2+ concentration 1– 2 mM 1– 10 mM
pH 8.0–9.2 6.0– 10.0
Temperature 37jC 0 –42jC
Dithiothreitol (DTT) 0– 100 mM >100 mM
h-Mercaptoethanol 0– 100 mM >100 mM
Monovalent cation concentration
(Na+, K+, etc.)
0– 20 mM 0– 150 mM
PO4
3 concentration 0– 10 mM 0– 100 mM
a‘‘Optimal’’ is defined as the operating range in which Benzonase retains
90% or more of its activity.
b‘‘Effective’’ is defined as the operating range in which Benzonase re-
tains at least 15% of its activity.
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improve Benzonase activity (see Table II). The diluted broth
was supplemented with 6 mM MgCl2 and 8.33 U mL
1 of
Benzonase before overnight (12–14 h) incubation at room
temperature. A 3-volumes buffer exchange (4,500 mL TE
buffer) was carried out at a constant TMP of 0.7 bar with
pulsed backwashing every 5 min throughout the filtration
process. Sampling and diafiltration procedures were as for
the preceding tests, except that retentate samples were
withdrawn at each half volume (750 mL) of buffer
exchange. After diafiltration, the retentate was concentrated
2-fold to 750 mL over 82 min, using the same membrane
without cleaning. This facilitated a comparison of IB yields
following centrifugation or microfiltration and Benzonase
treatment. A one-time-recycled 0.2 Am monotube (used in
the microfiltration of the sheared chemical extraction broth)
was used. The recycled monotube was restored to 95% of
the original clean water flux prior to this filtration using the
cleaning procedures in the next section.
Clean Water Flux Measurement and Membrane
Regeneration
Clean water flux (CWF) was measured by recirculating
deionised and 0.2 Am-filtered water at a cross flow-rate of
1 m3 h1 at a TMP of 1 bar and a temperature of 20jC. The
0.2 Am ceramic monotube was regenerated within the
cross-flow microfiltration unit based on the Cleaning-In-
Place procedures recommended by the unit supplier.
Refolding
GM-CSF IBs in the retentate from the Benzonase-treated
microfiltration experiment were collected by centrifugation
(10,000g, 25 min, 4jC) and were solubilised overnight at
4jC in GuHCl buffer (see Analytical Methods, above). The
denatured GM-CSF concentration was quantified by RP-
HPLC analysis and was adjusted to 0.7 F 0.1 mg mL1
using GuHCl buffer. This denatured GM-CSF solution
(100 AL) was renatured by 7-fold rapid dilution into 600 AL
of refolding buffer (50 mM Tris-HCl, 3 mM GSH, 0.3 mM
GSSG, 0.067 mg mL1 CuCl2, pH 8.0) for 48 h at 4jC to
give a final protein concentration of f0.1 mg mL1. A
control experiment was run to test whether the micro-
filtration and Benzonase treatment had reduced refolding
yield. IBs in the original chemical extraction mixture
(without Benzonase treatment) were recovered by centri-
fugation, as above. The IB pellet was solubilised and
refolded using the same procedures as described above at a
similar refolding concentration (0.08 mg mL1).
RESULTS AND DISCUSSION
Chemical Extraction
A primary objective of this work was to develop a non-
denaturing chemical extraction method for IBs that would be
suitable for subsequent microfiltration purification. Non-
denaturing extraction achieves a higher initial purity of
inclusion body (IB) material and is therefore useful when an
affinity system is not available to purify the denatured pro-
tein, or when there is advantage in maintaining a protective
IB state until contaminating proteins have been removed.
As a first step, we examined a selective chemical
extraction method developed previously (Falconer et al.,
1999). The method has been successfully used to recover
f80% (w/w) of Long-R3-IGF-I from cytoplasmic IBs at a
purity of 46% (w/w). The method first employed
a permeabilising buffer containing 6 M urea, 15 mM 2-hy-
droxyethyl disulphide, 3 mM ethylenediaminetetraacetic
acid (EDTA), 0.1 M Tris pH 9, to release contaminating
proteins. It was hypothesised that 2-HEDS stabilised the
IB against solubilisation, through surface oxidation of the di-
sulphide bonds. The IBs were then solubilised using the
same buffer, but with a reducing agent (DTT) replacing the
oxidising agent. In this work we attempted to use this same
approach for GM-CSF IBs. The addition of 20 mM 2-HEDS
into the permeabilising buffer used by Falconer et al. (1999)
failed to prevent GM-CSF IB solubilisation for all urea
concentrations tested (4 M, 6 M, and 8 M). IBs were found to
be solubilised within 30 min of incubation at 37jC. Falconer
et al. (1999) claimed that their method has higher likelihood
of success for recombinant proteins having a high proportion
of cysteine residues. Although the method was successful for
Long-R3-IGF-I, having three disulphide bonds in a protein of
83 amino acid residues, it failed for GM-CSF, which has two
disulphide bonds and 124 amino acid residues.
We therefore sought an alternative chemical extraction
system. We decided to employ a combination of Triton
X-100, urea, and lysozyme, as these agents act complemen-
tarily on different components of the cell wall (Middelberg,
1995). To avoid the cost of adding lysozyme we used a
host-vector system, E. coli BL21(DE3)pLysS (Novagen),
which constitutively expresses a small amount of lysozyme
intracellularly. This system is sold commercially and it is
well documented that cells will be easily lysed in the
presence of a small amount of mild detergent (e.g., 0.1%
Triton X-100) (Studier, 1991). A control system using the
commercial B-PER reagent (Pierce, 78243) was also inves-
tigated. The control used cells that had been separated from
fermentation media according to an established method
(see Materials and Methods), whereas other protocols used
cells suspended directly in fermentation media. Figure 1A,B
are SDS-PAGE gels of pellet and supernatant samples for
extraction protocols 2–5 summarised in Table I. A com-
parison of Figures 1A and B shows that the cleanest IB
pellets were obtained by a combination of Triton X-100 and
EDTA (protocols 4 and 5), whereas protocols 2 and 3 gave
poor product purity, as the pellet samples were quite dirty.
A combination of both Triton X-100 and EDTA, along with
constitutive lysozyme expression, is necessary to ensure
good purification. Efficient lysis by protocols 4 and 5 was
confirmed by the observation that considerable release of
nucleic acid occurred. From Figure 1B, the addition of 2 M
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urea did not improve extraction efficiency. Further tests on
protocol 4 also indicated that an increase in EDTA
concentration to 10 mM (protocol 6 in Table I) did not
further improve extraction efficiency (data not shown). To
reduce downstream impact and cost, we also sought
to reduce Triton X-100 concentration. A reduced Triton
X-100 concentration (0.05% v/v) was screened in the ex-
traction buffer containing 5 mM EDTA, 0.1 M Tris, pH 9
(protocol 7 in Table I). The result, as shown in Figure 2,
was comparable to that achieved using 0.1% Triton X-100
(protocol 4, Fig. 1B). This modified extraction protocol
gave an IB pellet of comparable purity to that obtained
using B-PER reagents (as shown in Fig. 2), and was the
method chosen for further investigation in a larger-scale
extraction test.
A larger scale extraction was conducted in 4-L of
fermentation broth, directly in the fermenter. Figure 3 is an
SDS-PAGE gel comparing the result for large-scale
extraction with that from the optimised small-scale protocol
(protocol 7, Table I). The protocols are comparable to that
achieved by shake-flask extraction, and the purity of the IB
pellet obtained by centrifugation is very good. This in-
fermenter extraction method was therefore selected for
further microfiltration-based studies.
Cross-Flow Microfiltration
Having developed a successful nonsolubilising in-fermenter
extraction protocol, the next step was to develop a separation
method based on microfiltration. As stated in the Introduc-
tion, a key objective is to minimise the number of process
unit operations and eliminate the complexity associated with
repeated mechanical disruption and centrifugation.
In the first microfiltration test using an IB suspension
generated by in-fermenter extraction, a two-volumes buffer
exchange diafiltration was conducted at a low permeate flux
ranging from 50–75 L m2 h1 (Fig. 4). This low flux
necessitated an extended filtration time off12 h. Approxi-
mately 30% of soluble contaminating protein was removed.
It was hypothesised that filtration efficiency would be
improved by reducing nucleic acid (NA) size, thus lowering
both viscosity and the extent of gel-layer formation. A
reduction in NA size can be achieved using either shear or
enzymatic degradation (e.g., Benzonase). A hand-held mixer
was employed to assess the effect of shear on filtration
Figure 2. SDS-PAGE showing that the developed chemical extraction
method using protocol 7 (0.05% Triton X-100 and 5 mM EDTA, 0.1 M
Tris, pH 9) gave a comparable results to protocol 4 (shown in Fig. 1B) and
also the control experiment using a commercial extraction reagent, B-PER.
(1, induced whole cells; 2, uninduced whole cells; 3, supernatant sample
using B-PER; 4, pellet sample using B-PER; 5, supernatant sample of the
developed chemical extraction; 6, pellet sample of the developed chemical
extraction; M, marker.)
Figure 1. A: SDS-PAGE analysis for extraction protocols 2 and 3.
Samples 1 and 2 are the supernatant and pellet samples from protocol 2 (2 M
urea, 5 mM EDTA) following 30 min extraction; samples 3 and 4 are similar
to 1 and 2, but following an extraction time of 60 min; samples 5 and 6 are
the supernatant and pellet samples from protocol 3 (0.1% Triton X-100),
following 30 min of extraction time; samples 7 and 8 are similar to 5 and 6,
but following an extraction time of 60 min. B: A comparison of protocols
4 and 5. M, Marker; C, whole cell extract; samples 1 and 2 are the supernatant
and pellet samples from protocol 4 (0.1% Triton X-100, 5 mM EDTA)
following 30 min extraction; samples 3 and 4 are similar to samples 1 and 2,
but following an extraction time of 60 min; samples 5 and 6 are the
supernatant and pellet samples from protocol 5 (0.1% Triton X-100, 5 mM
EDTA, 2 M urea) following 30 min extraction; samples 7 and 8 are similar to
5 and 6, but following an extraction time of 60 min.
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performance (see Materials and Methods). Protein removal
for sheared material increased to 58% after a 1.5 volume
diafiltration. A low average flux rate (f40 L m2 h1) was
still observed, leading to an extended diafiltration time (12 h)
(see Fig. 4). The system was not considered acceptable for
practical use.
To test the effect of enzymatic degradation, a large
number of tests were conducted with Benzonase. The aim
of Benzonase treatment was to create an extract having
a maximum NA size of f500 bp. Phosphate and EDTA
concentrations in the extraction mixture were high because
of the fermentation and extraction conditions, respectively.
These concentrations exceeded the recommended limits for
optimal Benzonase activity (see Table II), and dilution and
Mg2+ supplementation were required to achieve good NA
degradation with minimal Benzonase use. The final
conditions involved diluting the in-fermenter extract 2-fold
with TE buffer and the addition of Benzonase (8.33 U mL1
final concentration) and MgCl2 (6 mM), to give 1.5 L of
feed material at pH 8. This mixture was incubated
overnight (12–14 h) at room temperature prior to dia-
filtration. As shown in Figure 4, a microfiltration run using
this extract successfully removed 91% of soluble contam-
inant proteins after three volumes of buffer exchange in
f6 h. Microfiltration efficiency was greatly improved both
in terms of protein removal and flux. The filtration flux
remained abovef100 L m2 h1, which will be acceptable
for large-scale economic microfiltration (Kroner et al.,
1984). Following diafiltration, the retentate was concen-
trated 2-fold to restore the IB concentration in the original
chemical extract (i.e., to compensate for the 2-fold dilution
prior to Benzonase treatment). The diafiltration retentate
and the 2-fold concentrated retentate samples were sampled
and sedimented by centrifugation to give a pellet and
supernatant sample suitable for SDS-PAGE analysis. A
sample of the feed to the microfiltration system (i.e., the in-
fermenter extract without 2-fold dilution) was also retained
and analysed in parallel. Figure 5 gives a comparison of
these samples. It is clear that microfiltration gives an IB
product (Fig. 5, sample 4) that is of similar purity to that
obtainable by centrifugation (Fig. 5, sample 2). The reten-
tates also contain very little soluble contaminating protein
(as evidenced in Fig. 5, samples 5 and 7), and the IB yield
following filtration and 2x concentration is comparable to
that obtained by centrifugation of the undiluted feed mate-
rial (as evidenced by comparable GM-CSF pellet bands in
both sample 4 (microfiltration) and sample 2 (centrifuga-
tion)). SDS-PAGE analysis of permeate samples confirmed
no loss of IBs through the microfiltration membrane (data
not shown).
Denaturation and Refolding of GM-CSF
Two samples of cleaned IBs were tested for their refolding
ability. The first sample was a control using IBs collected by
centrifugation following extraction using the in-fermenter
protocol (protocol 7 in Table I, no Benzonase treatment).
The second sample consisted of IBs pelleted from the
concentrated retentate (i.e., the final microfiltration sample
generated above and analysed in Fig. 5, sample 4). Both
samples were solubilised in denaturing buffer (7 M GuHCl,
50 mM DTT, 50 mM Tris, 1 mM EDTA, pH 8, overnight at
4jC). Analysis by RP-HPLC showed that the denatured
samples were similar. Both samples also gave comparable
refolding yields (23% for the concentrated retentate refolded
Figure 4. Flux versus time for cross-flow microfiltration runs using 2-
fold diluted extract (closed circles), 2-fold diluted extract sheared with a
hand-mixer device (open circles), and 2-fold diluted extract treated with
Benzonase (closed triangles).
Figure 3. SDS-PAGE of the pellet and supernatant samples following
larger scale chemical extraction using protocol 7 (0.05% Triton X-100,
5 mM EDTA, 0.1 M Tris, pH 9) performed in 4 L of fermentation broth.
The extraction result was comparable to results for smaller scale ex-
traction performed in a 10-mL shake flask as shown in Figure 2. (M,
marker; C, whole cell extract; P, pellet sample of extract; S, supernatant
sample of extract.)
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at a refolding protein concentration of 0.11 mg mL1, and
24% for the pelleted extract refolded at 0.08 mg mL1). This
result confirms that the IBs were not affected by the extended
Benzonase and diafiltration treatments, as the folding charac-
teristics remained similar. Moreover, independent tests on
IBs prepared using conventional methods suggest a refold-
ing yield of 20–30% is reasonable for GM-CSF for the re-
folding buffer conditions employed in this work (Ho, 2003).
Further Discussion
The preceding results confirm that an in-fermenter
extraction protocol for E. coli cells containing cytoplasmic
IBs has been successfully developed, and that the extract
can be processed by microfiltration to give a relatively pure
IB suspension. Addition of powdered chaotrope to the final
retentate will yield a solubilised IB mixture suitable for
subsequent refolding. In this way a denatured protein ready
for refolding can be obtained in a relatively pure form using
only two unit operations: a fermenter and a microfiltration
system. This process eliminates the need for repeated
mechanical disruption and centrifugation and, importantly,
allows the definition of a single integrate fermenter-
filtration domain for validation purposes. Figure 6 provides
a direct comparison of the conventional process with our
modified process. The integrated process also offers scope
for further intensification, as the IBs may be solubilised and
refolded directly in the diafiltration system (Vicik and
Clark, 1991). The current extraction protocol using a
combination of cytoplasmic lysozyme, EDTA, and 0.05%
(v/v) Triton X-100 effectively disrupts the E. coli wall and
maintains the protective IB state during initial purification.
The technique is effective even in the presence of fermen-
tation media, eliminating the need for a cell recovery and
resuspension in buffer. It is expected to be reasonably
universal for disrupting E. coli cells; in the case where
lysozyme is not constitutively expressed within the cell, the
in vitro addition of lysozyme may prove to be an accept-
able alternative.
Suboptimality remains in the current process because of
the need to use costly Benzonase prior to microfiltration.
For many products this cost will be minimal when offset
against the savings achieved by the elimination of two
major unit operations (e.g., homogenisation and centrifu-
gation). However, Benzonase cost may present a barrier for
some commodity protein products. For such products it
may be possible to genetically modify the cells to express,
toward the end of the fermentation cycle, enzymes that
degrade nucleic acids. Such a strategy would mimic the
approach used in this study to avoid in vitro lysozyme
addition. A genetically modified E. coli strain capable of
degrading nucleic acids has recently been developed by a
team of academic and industrial researchers for use in
large-scale bioprocessing (Cooke et al., 2003).
The viscosity increase caused by the release of nucleic
acids proved to be the major problem that had to be overcome
in this work. In previous filtration studies reporting the high
removal of soluble protein (80–90%) (Meagher et al., 1994;
Forman et al., 1990; Bailey and Meagher, 2000), the feed
material for microfiltration was a cell suspension that had
been mechanically disrupted. Homogenate produced by
repeated mechanical treatment has a significantly reduced
NA fragment size, giving a viscosity suitable for filtration. In
another successful microfiltration study using 0.65 Am
Nylon 66 membranes to recover a small soluble protein,
Staphylokinase (SAK), from the permeabilised cell extract,
cell permeability was controlled by adequate chemical
selection to limit the release of DNA (Gehmlich et al., 1997).
Figure 6. A comparison of the current integrated system with the
conventional approach for IB processing.
Figure 5. SDS-PAGE showing that the purity of IBs obtained by
diafiltration were comparable to the pellet via centrifugation. (1, whole cell
chemical extract; 2, pellet sample of the chemical extracts; 3, supernatant
sample of the chemical extracts; 4, pellet sample of the 2 concentrated
final retentate after 3 volumes of buffer exchange; 5, supernatant sample of
the 2 concentrated final retentate after 3 volumes of buffer exchange; 6,
pellet sample of the final retentate (the initial extract was diluted 1:1 with
TE buffer); 7, supernatant sample of the final retentate.)
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In that study, only 25% of the total SAK was released in the
supernatant by using the combination of 0.1% Triton X-100
and 0.1 M GuHCl to permeabilise the E. coli cells.
Microfiltration yield and initial flux both dropped by about
33% when DNA release was enhanced from 5 to 10% due to
higher degree of cell permeabilisation, confirming the
significant deleterious effect that DNA has on filtration
performance. However, partial permeabilisation will not be
suitable for the current study, where the product is an
insoluble IB. To investigate the viscosity problem further,
DNA size was analysed using agarose gel electrophoresis.
Figure 7 shows the results for samples following various
treatments. Following chemical extraction and incubation,
DNA in the suspension had a size greater than 12 kbp. The
use of high-power of a hand-mixer to shear the DNA
fragments reduced the fragment size to below f10 kbp, a
small improvement. This size range is still considerably
larger than the 500 bp limit observed following repeated
mechanical disruption (Choe, 2002). Initial experiments
with Benzonase treatment showed that DNA molecules
greater than 10 kbp could be degraded to <76 bp using
50 U mL1 Benzonase following a 2-fold dilution of the in-
fermenter extract (see Fig. 7). A slower digestion rate was
observed under similar conditions when the extract was not
diluted, presumably because of the high phosphate concen-
trations (at least 54 mM K2HPO4 and 16 mM of KH2PO4,
exceeding the optimal limits defined in Table II). Also, no
digestion was observed in either case when MgCl2 was not
added to the extract to bind EDTA used in the extraction
procedure. Tests showed that 6 mM MgCl2 was sufficient
to bind the 2.5 mM of EDTA in the diluted extract while
also providing sufficient enzyme cofactor. Dilution of the
extract, though not critical for DNA degradation, was antici-
pated to significantly improve the digestion rate, allowing
a significant reduction in Benzonase concentration. In
subsequent experiments aimed at reducing Benzonase con-
centration, 2-fold diluted extract was treated at room
temperature with 6 mM MgCl2 at 10–50 U mL
1 of
Benzonase. Figure 7 shows that DNA fragment size can be
easily reduced below 220 bp in 30 min using >20 U mL1
Benzonase, with a significant improvement in performance
following overnight incubation. Even a low concentration of
10 U mL1 of Benzonase could achieve an acceptable DNA
size following overnight incubation.
CONCLUSIONS
The viability of recovering GM-CSF IBs expressed within
E. coli using nonsolubilising chemical extraction and cross-
flow microfiltration was demonstrated. The extraction
protocol, based on a combination of Triton X-100, EDTA,
and intracellular T7 lysozyme, effectively released most of
the intracellular soluble content without solubilising the
GM-CSF IBs. A cross-flow microfiltration using a 0.2 Am
ceramic membrane successfully recovered the GM-CSF IBs
with removal of 91% of the soluble contaminants and
virtually no loss of IBs to the permeate. The filtration
efficiency both in terms of flux and transmission level was
enhanced significantly by reducing the DNA fragment size
with Benzonase digestion. Both the extraction and filtration
methods exerted their efficacy directly on a crude fermen-
tation broth, eliminating a step for medium removal. The
recovered IBs had purity comparable to that obtained via
centrifugation following similar chemical extraction. We
also demonstrated that, following extraction and Benzonase
treatment, the IBs recovered from the retentate of a
microfiltration run exhibited similar refolding characteristic
to those recovered by centrifugation. Importantly, the
processes demonstrated here can all be performed using
just a fermenter and a single unit of cross-flow filtration
unit, demonstrating a high level of IB process intensifica-
tion. Furthermore, there is considerable scope to also use a
microfiltration system to subsequently solubilise the IBs, to
separate the denatured protein from cell debris, and to refold
the protein using diafiltration. In this way refolded protein
can potentially be obtained, in a relatively pure state, using
only two unit operations.
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